PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO REC...

por De La Fuente, A., Peñalver, F. J., Herrera, P., Cordoba, R., Martinez Chamorro, C., Olave, M. T., Jarque, I., Navarro, M. B., Estévez, M.
Publicado 2022

PB2105: REAL WORLD EXPERIENCE WITH POLATUZUMAB IN COMBINATION WITH BENDAMUSTINE AND RITUXIMAB FOR R/R DLBCL IN 3 ACADEMIC CENTERS IN MADRID, SPAIN.

por Corrochano, M., Nistal, S., Pradillo, V., Alonso, A., Alaez, C., Tercero-Mora, M., Delgado, I., Sanchez, J. M., Marti, E., Segado, A., Benzo, G., Escudero, A., Fernández-Rañada, J. M., Martinez Chamorro, C.
Publicado 2022